Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection

Combination therapy for eradicating detectable HCV-RNA in patients having chronic Hepatitis C infection

US Patent 6172046 · Granted Jan 9, 2001

Estimated economic value: $873,067,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ribavirin-pegylated interferon alfa induction HCV combination therapy2004
Combination therapy for eradicating detectable HCV-RNA in antiviral treatment na2002
Combination therapy for chronic hepatitis C infection2002
Combination therapy for chronic hepatitis c infection2001